Skip to main content
SpringerLink
Log in

Nosokomiale Pneumonie – Antibiotikatherapie und krankenhaushygienische Interventionsstrategien

  • Chapter
NeuroIntensiv

  • 3766 Accesses

Zusammenfassung

Die Pneumonie ist auch in unserer Zeit eine schwere Infektionskrankheit. Sie steht in der Todesursachenstatistik der westlichen Industrieländer an 5. Stelle und an 1. Stelle unter den Infektionskrankheiten. Jede 4. ärztlich diagnostizierte Pneumonie ist nosokomial erworben. Nosokomiale Pneumonien führen neben einer verlängerten Morbidität und erhöhten Letalität zu einer Verlängerung der Krankenhausverweildauer und zu erheblichen Kosten.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. American Thoracic Society (ATS). Guidelines for the management of adults with hospital-acquired, ventilatorassociated and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388–416

    Article  Google Scholar 

  2. AWMF. S3-Leitlinie. Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen tiefen Atemwegsinfektionen sowie ambulant erworbener Pneumonie. www.awmf.org/uploads/tx_szleitlinien/082-001_S3_Epidemiologie__Diagnostik__antimikrobielle_Therapie_und_Management_von_erwachsenen_Patienten_mit_ambulant_erworbenen_tiefen_Atemwegsinfektionen_07-2009_12-2012.pdf

  3. Beck-Schimmer B, Bonvini JM. Bronchoaspiration: incidence, consequences and management. Eur J Anaesthesiol 2011; 28:78–84

    Article  PubMed  Google Scholar 

  4. Brodmann KF, Lorenz F, Bauer TT, Ewig S, Trautmann M, Vogel F. Nosokomiale Pneumonie: Prävention, Diagnostik und Therapie. - Konsenspapier der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG) und der Deutschen Gesellschaft für Pneumologie (DGP) unter Mitarbeit der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI) Chemotherapie Journal 2003; 12:33–44

    Google Scholar 

  5. Centers for Disease Control and Prevention (CDC). Guidelines for prevention of nosocomial pneumonia. MMWR 1997; 46:1–79

    Google Scholar 

  6. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867–903

    PubMed  Google Scholar 

  7. Ciche L, Forel JM, Papazian L. The role of viruses in nosocomial pneumonia. Curr Opin Inf Dis 2011; 24:152–156

    Article  Google Scholar 

  8. Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, Peters S, Rutledge F, Griffith L, McLellau A, Wood G, Kirby A. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998; 338:791–797

    Article  PubMed  CAS  Google Scholar 

  9. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeschke RZ, Brun-Buisson C. Incidence and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998; 129:433–440

    PubMed  CAS  Google Scholar 

  10. Craven DE, Steger KA. Epidemiology of nosocomial pneumonia- New perspectives on an old disease. Chest 1995; 108 (Suppl):1S-16S

    Article  PubMed  CAS  Google Scholar 

  11. Daschner FD. Krankenhausinfektionen in einem Universitätsklinikum. DMW 1981; 106:101–105

    Article  CAS  Google Scholar 

  12. Davidson R, Cavalcanti R, Brunton JL, Bast DJ, de Azavedo JC, Kibsey P, Fleming C, Low DE. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med 2002; 346:747–750

    Article  PubMed  Google Scholar 

  13. De Jong E, Schultz MJ, Spanjaard L, Bossuyt PMM, Vroom MB, Dankert J, Kesecioglu J. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003; 362:1011–1016

    Article  Google Scholar 

  14. Ewig S. Healthcare-associated pneumonia-ist diese neue Entität für die Diagnostik und Therapie vonPneumonien wichtig? Dtsch Med Wochenschr 2010; 135:467

    Article  PubMed  CAS  Google Scholar 

  15. Fiel S. Guidelines and critical pathways for severe hospitalacquired pneumonia. Chest 2001; 119 (Suppl 1):412–418

    Article  Google Scholar 

  16. Garner JS, Emori WR, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16:128–140

    Article  PubMed  CAS  Google Scholar 

  17. Gastmeier P, Geffers C. Nosokomiale Infektionen in Deutschland: wie viele gibt es wirklich? Dtsch Med Wochenschr 2008; 133:1111–1115

    Article  PubMed  CAS  Google Scholar 

  18. Gastmeier P, Sohr D, Geffers C, Rüden H, Vonberg RP, Welte T. Early- and late-onset pneumonia: is this still a useful classification? Antimicrob Agents Chemother 2009; 53:2714–2718

    Article  PubMed  CAS  Google Scholar 

  19. Gastmeier P. Zur Entwicklung nosokomialer Infektionen im Krankenhaus-Infektions-Surveillance-System (KISS). Epidemiol Bull 2011; 5:35–37.

    Google Scholar 

  20. George DL. Epidemiology of nosocomial pneumonia in intensive care unit patients. Clin Chest Med 1995; 16:29–44

    PubMed  CAS  Google Scholar 

  21. Haley RW, Quade DH, Freeman HE, the CDC SENIC Planning Committee. Study on the efficacy of nosocomial infection control (SENIC Project): Summary of study design. Am J Epidemiol 1980; 111:472–480

    PubMed  CAS  Google Scholar 

  22. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, Plouffe JF, Rakowsky A, Schuchat A, Whitney GG. Management of communitiy-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 2000; 160:1399–1408

    Article  PubMed  CAS  Google Scholar 

  23. Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS). Consensus guidelines on the management of community-acquired pneumonia in adults. CID 2007; 44:S27–72.

    Article  Google Scholar 

  24. International Nosocomial Infection Control Consortium (INICC). INICC report, data summary for 2003–2008, issued June 2009. Am J Infect Control 2010; 38:95–106

    Article  Google Scholar 

  25. Kalil AC, Florescu DF. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 2009; 37:2350–2358

    Article  PubMed  Google Scholar 

  26. Kett DH, Cano E, Quartin AA, Mangino JE, Zervos MJ, Peyrani P, Cely CM, Ford KD, Scerpella EG, Ramirez JA, and the Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis 2011; 11:181–189

    Article  PubMed  Google Scholar 

  27. Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev 2006; 19:637–657

    Article  PubMed  Google Scholar 

  28. Kollef MH. The prevention of ventilator-associated pneumonia. N Engl J Med 1999; 340:627–634

    Article  PubMed  CAS  Google Scholar 

  29. Kollef MH, Morrow LE, Baughman RP, Craven DE, McGowan JE, Scott T, Micek MS, Niederman MS, Ost D, Paterson DL, Segreti J. Healthcare-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes - Proceedings of the HCAP Summit. Clin Infect Dis 2008; 46:S296-S334

    Google Scholar 

  30. KRINKO - Kommission für Krankenhaushygiene und Infektionsprävention am Robert-Koch-Institut. Prävention der nosokomialen Pneumonie. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2000; 43:302–309

    Article  Google Scholar 

  31. Marik PE, Careau P. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study. Chest 1999; 115:178–183

    Article  PubMed  CAS  Google Scholar 

  32. Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG). Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen - Update 2010. www.p-e-g.org/econtext/leitlinien

  33. Reinhart K, Brunkhorst FM, Bone HG et al., and the German Interdisciplinary Association for Intensive and Emergency Care Medicine, and the German Sepsis Society. Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI). Anaesthesist 2010; 59:347–370

    Article  PubMed  CAS  Google Scholar 

  34. Robert Koch Institut (RKI). Vorwort zur 16. Lieferung (Feb. 2000) der Loseblattsammlung: Richtline für Krankenhaushygiene und Infektionsprävention. Urban & Fischer, München

    Google Scholar 

  35. Robert Koch Institut (RKI). Prävention der nosokomialen Pneumonie. Bundesgesetzbl-Gesundheitsforsch- Gesundheitsschutz 2000; 43:302–309

    Article  Google Scholar 

  36. Robert Koch Institut (RKI). Definitionen nosokomialer Infektionen (CDC-Definitionen). RKI, 7. Aufl. Berlin 2011

    Google Scholar 

  37. Rotstein C, Evans G, Born A, Grossman R, Light B, Magder S, McTaggart B, Weiss K, Zhanle GG. Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol 2008; 19:19–53

    PubMed  Google Scholar 

  38. Schaaf B. Healthcare-associated pneumonia-ist diese neue Entität für die Diagnostik und Therapie vonPneumonien wichtig? Dtsch Med Wochenschr 2010; 135:466

    Article  PubMed  CAS  Google Scholar 

  39. Scheld WM, Mandell GL. Nosocomial pneumoniae: Pathogenesis and recent advances in diagnosis and therapy. Rev Infect Dis 1991; 13 (Suppl 9):743–751

    Article  Google Scholar 

  40. Tablan OC, Anderson LJ, Arden NH, Breimann RF, Butler JC, Mc Neil MM, and the Hospital Infection Control Practices Advisory Committee. Guidelines for prevention of nosocomial pneumonia. Infect Control and Hosp Epidemiol 1994; 15:587–627

    Article  CAS  Google Scholar 

  41. Torres A, Ewig S, Lode H, Carlet J, for the European HAP working group. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 2009; 35:9–29

    Article  PubMed  Google Scholar 

  42. Unertl K, Ruckdeschel G, Lechner S, Strohmeier E, Jensen U. Nosokomiale postoperative und posttraumatische Pneumonien. In: Lode H, Kemmrich B, Klastersky B (Hrsg) Aktuelle Aspekte der bakteriellen und nichtbakteriellen Pneumonien. Thieme 1984, Stuttgart, S 39–43

    Google Scholar 

  43. Unertl K, Lenhart FP, Fort H, Peter K. Systemic antibiotic treatment of nosocomial pneumonia. Intensive Care Med 1992; 18:28–34

    Article  Google Scholar 

  44. Zuschneid I, Schwab F, Geffers C, Behnke M, Rüden H, Gastmeier P. Trends in ventilator-associated pneumonia rates within the German Nosocomial Infection Surveillance System (KISS). Infect Control Hosp Epidemiol 2007; 28:314–318

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Hygiene und Mikrobiologie, Universität Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg

    Prof. Dr. M. Abele-Horn

  2. Institut für Krankenhaushygiene und Infektionskontrolle GbR, Siemensstr. 18, 35394, Gießen

    PD Dr. F.-A. Pitten

Authors
  1. Prof. Dr. M. Abele-Horn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. PD Dr. F.-A. Pitten
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen

    Stefan Schwab

  2. Benediktuskrankenhaus, Neurologische Klinik und Geriatrie Johannes Wesling Klinikum Minden, Hans-Nolte-Str. 1, 32429, Minden

    Peter Schellinger

  3. Klinik für Anästhesiologie, Klinikum der Johannes Gutenberg-Universität Mainz, Langenbeckstr. 1, 55131, Mainz

    Christian Werner

  4. Neurochirurgische Klinik, Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg

    Andreas Unterberg  & Werner Hacke  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Abele-Horn, M., Pitten, FA. (2012). Nosokomiale Pneumonie – Antibiotikatherapie und krankenhaushygienische Interventionsstrategien. In: Schwab, S., Schellinger, P., Werner, C., Unterberg, A., Hacke, W. (eds) NeuroIntensiv. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16911-3_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-16911-3_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-16910-6

  • Online ISBN: 978-3-642-16911-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation